IPL576,092, a novel anti-inflammatory compound, inhibits leukocyte infiltration and changes in lung function in response to allergen challenge

Pulmonary Pharmacology and Therapeutics

Volumn 17, Issue 5, 2004, Pages 309-318

  Kasserra, C E ^a   Harris, P ^a   Stenton, G R ^a   Abraham, W ^a   Langlands, J M ^a  

^a Inflazyme Pharmaceuticals Ltd   (Canada)

Author keywords

Airway hyperresponsiveness; Asthma; Bronchoconstriction; Inflammation; Therapeutic

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; BRONCHOCONSTRICTING AGENT; CORTICOSTERONE; DEXAMETHASONE; IPL 576092; LEAD; OVALBUMIN; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; ASCARIS SUUM; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GUINEA PIG; LEUKOCYTE COUNT; LUNG FUNCTION; LUNG LAVAGE; LUNG RESISTANCE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFLAMMATION; SHEEP; SPLEEN; THYMUS;

AIRWAY RESISTANCE; ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; FEMALE; GUINEA PIGS; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; RATS; SHEEP; STEROLS;

EID: 5144223575     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.07.003     Document Type: Article

References (38)

1. C.P. Nielson, and N.E. Hadjokas Beta-adrenoceptor agonists block corticosteroid inhibition in eosinophils Am J Respir Crit Care Med 157 1998 184 191
2. D. Proud, C.J. Reynolds, L.M. Lichtenstein, A. Kagey-Sobotka, and A. Togias Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration Clin Exp Allergy 28 1998 868 875
3. R.A. McIvor, E. Pizzichini, M.O. Turner, P. Hussack, F.E. Hargreave, and M.R. Sears Potential masking effects of salmeterol on airway inflammation in asthma Am J Respir Crit Care Med 158 1998 924 930
4. M.R. Sears Asthma treatment: inhaled beta-agonists Can Respir J 5 1998 54A 59A
5. B.J. Lipworth Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis Arch Intern Med 159 1999 941 955
6. H. Bisgaard Leukotriene modifiers in pediatric asthma management Pediatrics 107 2001 381 390
7. A.R. Leff Regulation of leukotrienes in the management of asthma: biology and clinical therapy Annu Rev Med 52 2001 1 14
8. L.J. Smith Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma BioDrugs 15 2001 239 249
9. H.S. Nelson Combination therapy of bronchial asthma Allergy Asthma Proc 22 2001 217 220
10. P.H. Howarth The airway inflammatory response in allergic asthma and its relationship to clinical disease Allergy 50 1995 13 21
11. M.J. van der Veen, R.J. Van Neerven, E.C. De Jong, R.C. Aalberse, H.M. Jansen, and J.S. van der Zee The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5 Clin Exp Allergy 29 1999 217 227
12. V.M. Keatings, B.J. O'Connor, L.G. Wright, D.P. Huston, C.J. Corrigan, and P.J. Barnes Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum J Allergy Clin Immunol 99 1997 693 698
13. D. Burgoyne, R.J. Anderson, and T.M. Allen Contignasterol, a highly oxygenated steroid with the unnatural 14 beta configuration from the marine sponge petrosia contignata thiele, 1899 J Org Chem 57 1992 525 528
14. M. Takei, D.L. Burgoyne, and R.J. Andersen Effect of contignasterol on histamine release induced by anti-immunoglobulin E from rat peritoneal mast cells J Pharm Sci 83 1994 1234 1235
15. A.M. Bramley, J.M. Langlands, A.K. Jones, D.L. Burgoyne, Y. Li, R.J. Andersen, and H. Salari Effects of IZP-94005 (contignasterol) on antigen-induced bronchial responsiveness in ovalbumin-sensitized guinea-pigs Br J Pharmacol 115 1995 1433 1438
16. Y. Shen, and D.L. Burgoyne Efficient synthesis of IPL576,092: a novel anti-asthma agent J Org Chem 67 2002 3908 3910
17. W.M. Abraham, A. Ahmed, A. Cortes, M.W. Sielczak, W. Hinz, and J. Bouska The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep Eur J Pharmacol 217 1992 119 126
18. E. Hamelmann, J. Schwarze, K. Takeda, A. Oshiba, G.L. Larsen, C.G. Irvin, and E.W. Gelfand Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography Am J Respir Crit Care Med 156 1997 766 775
19. K. Ishida, L.J. Kelly, R.J. Thomson, L.L. Beattie, and R.R. Schellenberg Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs J Appl Physiol 67 1989 1133 1139
20. K. von Neergaard Die Messung der Stromungswiderstand in den Atemwegen des Menschen, inbesondere bei Asthma aund Emphysem Z Klin Med 105 1927 51 82
21. M.S. Ludwig, F.M. Robatto, P.D. Sly, M. Browman, J.H. Bates, and P.V. Romero Histamine-induced constriction of canine peripheral lung: an airway or tissue response? J Appl Physio 71 1991 287 293
22. L.N. Khan, O.M. Kon, A.J. Macfarlane, Q. Meng, S. Ying, N.C. Barnes, and A.B. Kay Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin Am J Respir Crit Care Med 162 2000 1377 1382
23. B.M. Haselden, M. Larche, Q. Meng, K. Shirley, R. Dworski, and A.P. Kaplan Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid J Allergy Clin Immunol 108 2001 394 401
24. R.E. Santing, C.G. Olymulder, J. Zaagsma, and H. Meurs Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs J Allergy Clin Immunol 93 1994 1021 1030
25. G. Cieslewicz, A. Tomkinson, A. Adler, C. Duez, J. Schwarze, and K. Takeda The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration J Clin Invest 104 1999 301 308
26. M. Silvestri, S. Oddera, O. Sacco, A. Balbo, E. Crimi, and G.A. Rossi Bronchial and bronchoalveolar inflammation in single early and dual responders after allergen inhalation challenge Lung 175 1997 277 285
27. D.M. Walter, J.J. McIntire, G. Berry, A.N. McKenzie, D.D. Donaldson, R.H. DeKruyff, and D.T. Umetsu Critical role for IL-13 in the development of allergen-induced airway hyperreactivity J Immunol 167 2001 4668 4675
28. K.G. Tournoy, J.C. Kips, and R.A. Pauwels The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent J Immunol 166 2001 6982 6991
29. M.J. Leckie, A. ten Brinke, J. Khan, Z. Diamant, B.J. O'Connor, and C.M. Walls Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
30. M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp, and D.D. Donaldson Interleukin-13: central mediator of allergic asthma Science 282 1998 2256 2261
31. G. Grunig, M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, and D.M. Rennick Requirement for IL-13 independently of IL-4 in experimental asthma Science 282 1998 2261 2263
32. A. Trifilieff, Y. Fujitani, A.J. Coyle, M. Kopf, and C. Bertrand IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation Clin Exp Allergy 31 2001 934 942
33. S.T. Holgate, P.M. Lackie, D.E. Davies, W.R. Roche, and A.F. Walls The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma Clin Exp Allergy 29 1999 90 95
34. A. Becker Clinical evidence with montelukast in the management of chronic childhood asthma Drugs 29-34 2000 43 45
35. S.I. Wasserman Immunopharmacologic profile of nedocromil sodium Allergy Proc 16 1995 67 71
36. K.M. Rocchiccioli, and P.A. Riley Clinical pharmacology of nedocromil sodium Drugs 37 1989 123 136
37. D. Ihaku, L. Cameron, M. Suzuki, S. Molet, J. Martin, and Q. Hamid Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats J Allergy Clin Immunol 104 1999 1147 1154
38. M. Soler, M. Sielczak, and W.M. Abraham Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep J Appl Physiol 70 1991 617 623